Google
ASMB — ASSEMBLY BIOSCIENCES INC (Healthcare >> Biotechnology)
ASMB FAQ
What is ASMB's P/E ratio?
ASSEMBLY BIOSCIENCES INC (ASMB) currently trades at a P/E ratio of 20.51.
What is ASMB's ROE?
ASSEMBLY BIOSCIENCES INC reports a Return on Equity (ROE) of -3.21%.
What is ASMB's dividend yield?
ASSEMBLY BIOSCIENCES INC offers a dividend yield of 0.00%.
What is ASMB's Deepscope Quality Score?
Deepscope rates ASMB's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy ASMB?
Deepscope's AI Timing Score for ASMB is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does ASMB belong to?
ASSEMBLY BIOSCIENCES INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 22.26
Price
-0.46
(-2.02%)
Day Change
|
|
|---|
ASMB, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
39% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 22.26 |
| PBV / Sector |
2.28 / 4.79
|
| Earning Per Share | -0.31 |
| PE / Sector |
20.51 / 17.89
|
| PEG or PE/Growth / Sector |
-0.34 / 0.56
|
| Average 1M Daily Value |
5.14 M
GREAT
|
| Average 1W Daily Value |
4.30 M
GREAT
|
| Timing Factors |
|
14% |
| Financial Health |
|
41% |
| ポイントになる統計 |
|
47% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-11 09:55:05 |
| Symbol | ASMB |
| Name | ASSEMBLY BIOSCIENCES INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 19.82 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 453.02 / 8,963.32 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: Two Tower Place, South San Francisco, CA, United States, 94080
Phone: 833 509 4583
Website: https://www.assemblybio.com
Employees: 73
Sector: Healthcare >> Biotechnology
Description: Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-5366 and ABI-1179, which are in Phase 1 clinical studies for recurrent genital herpes; and ABI-6250, an orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical study for the treatment of chronic hepatitis delta virus (HDV) infection. The company also develops ABI-4334, an orally bioavailable next generation capsid assembly modulator that is in Phase 1b study clinical trial for the treatment of chronic hepatitis B virus (HBV) infection; and ABI-7272, an oral broad-spectrum NNPI for the treatment of transplant-associated herpesviruses. It has an option, license, and collaboration agreement with Gilead Sciences, Inc. for the research and development of virology therapies. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
